(888) 552-6760 SCHEDULE AN APPOINTMENT

Robert R. Jenq,

M.D.

Hematologist-Oncologist

Biography photo
Location
City of Hope Duarte
1500 East Duarte Road
Duarte, CA 91010
Specialties
Hematologic Oncology
Education
Medical school:
Board Certifications & Licensures

Board Certifications

  • 2007-2027, American Board of Internal Medicine, Medical Oncology Certification

Licensures

  • 2024-2026, Medical Board of California, CA, C195813
Degrees
  • 2001, Doctor of Medicine, Oregon Health and Science University, Portland, Oregon
  • 1997, Bachelor of Arts, Chemistry, Princeton University, Princeton, New Jersey
Fellowship
  • 2007, Fellowship, Medical Oncology/Hematology, Memorial Sloan Kettering Cancer Center, New York, New York
Residency
  • 2004, Residency, Internal Medicine, Duke University, Durham, North Carolina
Professional Experience
  • 2024-present, Professor and Director, City of Hope Microbiome Program, Department of Hematology & Hematopoietic Cell Transplantation, City of Hope, Duarte, California
  • 2020-2024, Associate Professor, Departments of Genomic Medicine and Stem Cell Transplantation and Cellular Therapy, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas
  • 2019-2024, Deputy Chair, Department of Genomic Medicine, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas
  • 2016-2020, Assistant Professor, Departments of Genomic Medicine and Stem Cell Transplantation and Cellular Therapy, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas
  • 2013-2016, Assistant Member Tenure Track, Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York
  • 2007-2013, Assistant Member Level 1, Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York
Academic Appointments
  • Professor, Department of Hematology & Hematopoietic Cell Transplantation
  • Director, Microbiome Program, Department of Hematology & Hematopoietic Cell Transplantation
About Me

Robert R. Jenq, M.D., is the director of the Microbiome Program and a clinical professor in the Department of Hematology and Hematopoietic Cell Transplantation at City of Hope® Cancer Center Duarte. Dr. Jenq has more than 20 years’ experience in genomics, bone marrow and stem cell transplantation and conducting research that translates scientific advancements into real-world treatments for cancer patients. 

In his clinical practice, Dr. Jenq focuses on leukemia, lymphoma and other blood and bone marrow cancers, working closely with patients, their loved ones and their care teams to create treatment plans that are safe, effective and tailored to each person’s unique needs. 

Dr. Jenq received his medical degree from Oregon Health and Sciences University in Portland, then completed an internal medicine residency at Duke University in Durham, North Carolina. He went on to complete a clinical and research fellowship at Memorial Sloan Kettering Cancer Center in New York City. Before joining City of Hope, he was deputy chair of the Department of Genomic Medicine at MD Anderson’s Acute Cancer Care Center in Houston, Texas. 

As a researcher, Dr. Jenq has led and participated in numerous studies on blood and bone marrow transplantation and developed novel medical technologies. His work has explored important topics such as the role of the gut microbiome in graft-versus-host disease and neutropenic fever in patients undergoing hematopoietic stem cell transplants. He is currently engaged in collaborative research projects across the U.S., Canada, Germany and Japan.

Patient ratings
Star ratings and comments are only available for medical, radiation and gynecologic oncologists. Gynecologic surgical offerings are not included at this time due to a different survey tool required to evaluate these services. CTCA uses a validated Press Ganey® survey, which captures patient experience feedback for the primary oncology services of chemotherapy and radiation therapy at our comprehensive care and research centers. Following industry best practice, star ratings and comments are only published for physicians with a minimum of 30 completed patient surveys.